Endothelial dysfunction at the patients with COPD with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001
Pulmonary hypertension and endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007
Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 512s Year: 2005
Systemic inflammation and pulmonary hypertension in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007
Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 285s Year: 2002
Gender-related differences in pulmonary hemodynamics in patients with end-stage COPD Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange Year: 2005
Smoking induced pulmonary vascular remodelling in patients with mild COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007
Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010
Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013
Secondary pulmonary hypertension in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 348s Year: 2007
Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009
Endothelial dysfunction and pulmonary hypertension in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010
Platelet characteristics of patients with chronic obstructive pulmonary disease (COPD) accompanied with lung hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 226s Year: 2007
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD Source: Eur Respir J 2002; 19: 632-638 Year: 2002
The link between systemic inflammation and pulmonary hypertension in patients with stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 53s Year: 2005
Effects of bosentan in patients with severe pulmonary hypertension and mild-to-moderate COPD Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009
Stroke volume augmentation during exercise in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010
Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 768s Year: 2007